Obsidian Therapeutics, Inc.
OBX
$18.68
-$0.05-0.27%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -31.74% | -7.64% | |||
| Total Depreciation and Amortization | -13.24% | -1.06% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 23.62% | 64.32% | |||
| Change in Net Operating Assets | 71.24% | 415.65% | |||
| Cash from Operations | -14.80% | 11.79% | |||
| Capital Expenditure | -- | 98.21% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 100.00% | 27.23% | |||
| Cash from Investing | 100.24% | 27.75% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 1,593.62% | 100.00% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | 1,593.62% | 100.00% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 39.45% | 61.00% | |||